| Literature DB >> 35720692 |
Wenfei Sheng1, Shijue Li1, Jiangli Zhao1, Yujia Wang2, Zichong Luo2, Wai Leung Ambrose Lo1, Minghui Ding1, Chuhuai Wang1, Le Li3.
Abstract
Objective: Increased muscle co-contraction of the agonist and antagonist muscles during voluntary movement is commonly observed in the upper limbs of stroke survivors. Much remain to be understood about the underlying mechanism. The aim of the study is to investigate the correlation between increased muscle co-contraction and the function of the corticospinal tract (CST).Entities:
Keywords: correlation analyses; corticospinal tract; motor-evoked potential; muscle co-contraction; stroke
Year: 2022 PMID: 35720692 PMCID: PMC9198335 DOI: 10.3389/fnins.2022.886909
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 5.152
FIGURE 1The experimental setup. (A) The electromyography (EMG) evaluation during horizontal task. (B) The experimental setup for motor-evoked potentials (MEP) evaluation.
FIGURE 2The EMG signals of a typical trial from one stroke survivor captured during horizontal task. The EMG signal of flexor digitorum (FD) and extensor digitorum (ED) are shown together. (A) Affected side; (B) unaffected side.
Clinical characteristics of stroke survivors.
| Subject | Age | Gender | Paralyzed side | Stroke type | Month since stroke | FMA-UE | ARAT | MAS (wrist) |
| 1 | 57 | Male | Left | Ischemia | 4 | 53 | 38 | 1 |
| 2 | 68 | Male | Left | Hemorrhage | 2 | 66 | 57 | 0 |
| 3 | 38 | Male | left | Hemorrhage | 9 | 32 | 14 | 1+ |
| 4 | 31 | Male | Left | Hemorrhage | 2 | 61 | 35 | 0 |
| 5 | 69 | Male | Right | Ischemia | 2 | 54 | 38 | 1+ |
| 6 | 72 | Female | Left | Ischemia | 2 | 49 | 33 | 1 |
| 7 | 66 | Male | Left | Ischemia | 2 | 63 | 54 | 0 |
| 8 | 31 | Male | Left | Hemorrhage | 2 | 62 | 38 | 0 |
| 9 | 71 | Male | Left | Ischemia | 10 | 45 | 21 | 1+ |
FMA-UE, Fugl-Meyer Assessment Upper Extremity Scale; ARAT, Action Research Arm Test; MAS, Modified Ashworth Scale.
FIGURE 3The mean and standard deviation of root mean square of EMG data of all participants during horizontal task involved in the study. The significant difference between the groups is indicated by (*p < 0.05 with one-way ANOVA). ED, extensor digitorum; FD, flexor digitorum; BIC, biceps brachii; TRI, the triceps brachii.
The mean (M) and standard deviation (SD) of CI and MEP parameters of stroke survivors and the healthy group.
| Affected side (M ± SD) | Unaffected side (M ± SD) | Healthy group (M ± SD) | |
| CI (horizontal task) | 0.69 ± 0.13[ | 0.46 ± 0.18 | 0.44 ± 0.11 |
| MEP latency (ms) | 27.59 ± 5.14[ | 22.15 ± 1.67 | 22.19 ± 2.23 |
| Amplitude (μV) | 196.02 ± 163.68[ | 565.48 ± 334.98 | 366.85 ± 119.71 |
| rMT (% MSO) | 70.11 ± 19.64[ | 39.78 ± 6.67 | 47.33 ± 8.31 |
| CMCT (ms) | 12.46 ± 6.12[ | 7.32 ± 2.20 | 7.81 ± 1.33 |
MEP, motor-evoked potential; rMT, resting motor threshold; CMCT, central motor conduction time.
Correlation analyses between the motor function measures of affected limb, CI, and the MEP parameters of affected hemisphere.
| FMA-UE | ARAT | |
| CI | −0.318 ( | −0.433 ( |
| MEP latency (ms) | −0.883 ( | −0.729 ( |
| Amplitude (μV) | 0.117 ( | 0.153 ( |
| rMT (% MSO) | −0.406 ( | −0.504 ( |
| CMCT (ms) | −0.883 ( | −0.678 ( |
FMA-UE, Fugl-Meyer Assessment Upper Extremity Scale; ARAT, Action Research Arm Test; CI, co-contraction index; MEP, motor-evoked potential; rMT, resting motor threshold; CMCT, central motor conduction time.
FIGURE 4Scatter diagrams of clinical scales and MEP parameters on the affected side of stroke survivors. (A) MEP latency versus Fugl-Meyer assessment upper extremity scales. (B) CMCT of MEP versus Fugl-Meyer assessment upper extremity scales. (C) MEP latency versus ARAT. (D) CMCT of MEP versus ARAT. ARAT, Action Research Arm Test; CMCT, central motor conduction time.
FIGURE 5Scatter diagrams of the co-contraction index of flexor digitorum and extensor digitorum during horizontal task versus (A) MEP latency, (B) amplitude of MEP, (C) resting motor threshold of MEP, and (D) central motor conduction time of MEP.